MDMA and Oxytocin Changes in Autism and Healthy Adults
Treatments studied
Part of Mental health clinical trials.
This study tests whether a drug called MDMA changes oxytocin levels (a hormone related to social bonding) differently in autistic adults compared to non-autistic adults. Researchers want to understand if MDMA might help with social challenges some autistic people experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18+) with a confirmed autism diagnosis at level 1 (the support level that requires the least intensive support), OR you are a healthy adult with no autism diagnosis
- You have not taken any experimental drugs in the past 30 days
- You do not have a history of serious heart problems, high blood pressure, or recent stroke
- You do not have a current major mental health condition like depression or schizophrenia, and neither do your parents or siblings
- You are not pregnant or breastfeeding
- Your liver and kidney function are normal or only mildly impaired
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a nasal spray containing oxytocin can help youth with autism spectrum disorder. It focuses on participants who are healthy enough for the spray and able to follow study instructions, and it avoids people with certain nasal problems or allergies.
This trial studies whether oxytocin, given alongside structured psycho-educational support, can be safe and feasible in helping children with autism and moderate-to-severe intellectual disability who have challenging behaviors. It focuses on whether the added treatment can work without unacceptable side effects.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This trial tests an experimental drug called DT402 to see if it can improve social and communication skills in adults with autism. You may join if you are between 18 and 65, have a confirmed autism diagnosis, and have noticeable social challenges.
This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.
This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.